{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:07:52Z","timestamp":1776485272942,"version":"3.51.2"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria","award":["Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"],"award-info":[{"award-number":["Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00702-025-02957-5","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T03:46:54Z","timestamp":1750477614000},"page":"1085-1094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concomitant pathologies and their impact on Huntington\u2019s disease. A brief review of current evidence"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"2957_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/JHD-130054","volume":"2","author":"M Abildtrup","year":"2013","unstructured":"Abildtrup M, Shattock M (2013) Cardiac Dysautonomia in Huntington\u2019s disease. J Huntingtons Dis 2:251\u2013261","journal-title":"J Huntingtons Dis"},{"key":"2957_CR2","doi-asserted-by":"crossref","unstructured":"Achenbach J, Faissner S, Saft C (2021) Differential diagnosis of chorea-hiv infection delays diagnosis of Huntington\u2019s disease by years. Brain Sci 11:710","DOI":"10.3390\/brainsci11060710"},{"key":"2957_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00418-008-0393-z","volume":"129","author":"K Bacos","year":"2008","unstructured":"Bacos K, Bj\u00f6rkqvist M, Peters\u00e9n A, Luts L, Maat-Schieman ML, Roos RA, Sundler F, Brundin P, Mulder H, Wierup N (2008) Islet beta-cell area and hormone expression are unaltered in Huntington\u2019s disease. Histochem Cell Biol 129:623\u2013629","journal-title":"Histochem Cell Biol"},{"key":"2957_CR4","doi-asserted-by":"publisher","first-page":"e14325","DOI":"10.1111\/acel.14325","volume":"23","author":"D Bai","year":"2024","unstructured":"Bai D, Deng F, Jia Q, Ou K, Wang X, Hou J, Zhu L, Guo M, Yang S, Jiang G, Li S, Li XJ, Yin P (2024) Pathogenic TDP-43 accelerates the generation of toxic exon1 HTT in Huntington\u2019s disease knock-in mice. Aging Cell 23:e14325","journal-title":"Aging Cell"},{"key":"2957_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41374-018-0166-9","volume":"99","author":"SU Baskota","year":"2019","unstructured":"Baskota SU, Lopez OL, Greenamyre JT, Kofler J (2019) Spectrum of Tau pathologies in Huntington\u2019s disease. Lab Invest 99:1068\u20131077","journal-title":"Lab Invest"},{"key":"2957_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/ene.13630","volume":"25","author":"E Bellosta Diago","year":"2018","unstructured":"Bellosta Diago E, P\u00e9rez-P\u00e9rez J, Santos Lasaosa S, Viloria Alebesque A, Mart\u00ednez-Horta S, Kulisevsky J, Del L\u00f3pez J (2018) Neurocardiovascular pathology in pre-manifest and early-stage Huntington\u2019s disease. Eur J Neurol 25:956\u2013962","journal-title":"Eur J Neurol"},{"key":"2957_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/hmg\/ddu421","volume":"24","author":"D Blum","year":"2015","unstructured":"Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhardt E, Brouillet E, Bu\u00e9e L, Outeiro TF (2015) Mutant Huntingtin alters Tau phosphorylation and subcellular distribution. Hum Mol Genet 24:76\u201385","journal-title":"Hum Mol Genet"},{"key":"2957_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","volume":"21","author":"TW Boesgaard","year":"2009","unstructured":"Boesgaard TW, Nielsen TT, Josefsen K, Hansen T, J\u00f8rgensen T, Pedersen O, N\u00f8rrem\u00f8lle A, Nielsen JE, Hasholt L (2009) Huntington\u2019s disease does not appear to increase the risk of diabetes mellitus. J Neuroendocrinol 21:770\u2013776","journal-title":"J Neuroendocrinol"},{"key":"2957_CR9","doi-asserted-by":"crossref","unstructured":"Bragina EY, Gomboeva DE, Saik OV, Ivanisenko VA, Freidin MB, Nazarenko MS, Puzyrev VP (2023) Apoptosis genes as a key to identification of inverse comorbidity of Huntington\u2019s disease and cancer. Int J Mol Sci 24:9385","DOI":"10.3390\/ijms24119385"},{"key":"2957_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/JHD-190366","volume":"8","author":"IC Br\u00e1s","year":"2019","unstructured":"Br\u00e1s IC, K\u00f6nig A, Outeiro TF (2019) Glycation in Huntington\u2019s disease: a possible modifier and target for intervention. J Huntingtons Dis 8:245\u2013256","journal-title":"J Huntingtons Dis"},{"key":"2957_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroscience.2020.01.037","volume":"431","author":"M Breza","year":"2020","unstructured":"Breza M, Emmanouilidou E, Leandrou E, Kartanou C, Bougea A, Panas M, Stefanis L, Karadima G, Vekrellis K, Koutsis G (2020) Elevated serum alpha-synuclein levels in Huntington\u2019s disease patients. Neuroscience 431:34\u201339","journal-title":"Neuroscience"},{"key":"2957_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/cge.14472","volume":"105","author":"A Canosa","year":"2024","unstructured":"Canosa A, Cabras S, Di Pede F, Manera U, Vasta R, Moglia C, Calvo A, Gallone S, Chi\u00f2 A (2024) A mother and her daughter carrying a pathogenic expansion of the HTT gene with a phenotype encompassing motor neuron disease and Huntington\u2019s disease. Clin Genet 105:430\u2013433","journal-title":"Clin Genet"},{"key":"2957_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/jnnp-2016-314475","volume":"88","author":"F Cardoso","year":"2017","unstructured":"Cardoso F (2017) Autoimmune choreas. J Neurol Neurosurg Psychiatry 88:412\u2013417","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2957_CR14","doi-asserted-by":"publisher","first-page":"e1746","DOI":"10.1002\/ctm2.1746","volume":"14","author":"E Cattaneo","year":"2024","unstructured":"Cattaneo E, Barker RA (2024) Brain cholesterol therapy for Huntington\u2019s disease - Does it make sense? Clin Transl Med 14:e1746","journal-title":"Clin Transl Med"},{"key":"2957_CR15","doi-asserted-by":"crossref","unstructured":"Chang KH, Cheng ML, Lo CJ, Fan CM, Wu YR, Chen CM (2023) Alternations of lipoprotein profiles in the plasma as biomarkers of Huntington\u2019s disease. Cells 12:385","DOI":"10.3390\/cells12030385"},{"key":"2957_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3940(00)01247-7","volume":"289","author":"V Charles","year":"2000","unstructured":"Charles V, Mezey E, Reddy PH, Dehejia A, Young TA, Polymeropoulos MH, Brownstein MJ, Tagle DA (2000) Alpha-synuclein immunoreactivity of Huntingtin polyglutamine aggregates in striatum and cortex of Huntington\u2019s disease patients and Transgenic mouse models. Neurosci Lett 289:29\u201332","journal-title":"Neurosci Lett"},{"key":"2957_CR17","first-page":"28","volume":"23","author":"S Chatzikonstantinou","year":"2019","unstructured":"Chatzikonstantinou S, Dagklis I, Kazis D, Karantali E, Bostantjopoulou S (2019) Huntington\u2019s disease with comorbid myasthenia Gravis: a case report. Hippokratia 23:28\u201329","journal-title":"Hippokratia"},{"key":"2957_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/21678421.2013.817586","volume":"15","author":"SK Chhetri","year":"2014","unstructured":"Chhetri SK, Dayanandan R, Bindman D, Craufurd D, Majeed T (2014) Amyotrophic lateral sclerosis and Huntington\u2019s disease: neurodegenerative link or coincidence? Amyotroph Lateral Scler Frontotemporal Degener 15:145\u2013147","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2957_CR19","doi-asserted-by":"publisher","first-page":"149250","DOI":"10.1016\/j.brainres.2024.149250","volume":"1846","author":"K Cho","year":"2025","unstructured":"Cho K, Kim GW (2025) Decreased SREBP2 of the striatal cell relates to disrupted protein degradation in Huntington\u2019s disease. Brain Res 1846:149250","journal-title":"Brain Res"},{"key":"2957_CR20","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1212\/WNL.0000000000003725","volume":"88","author":"G Coarelli","year":"2017","unstructured":"Coarelli G, Diallo A, Thion MS, Rinaldi D, Calvas F, Boukbiza OL, Tataru A, Charles P, Tranchant C, Marelli C, Ewenczyk C, Tchikviladz\u00e9 M, Monin ML, Carlander B, Anheim M, Brice A, Mochel F, Montcel S, Humbert S, Durr A (2017) Low cancer prevalence in polyglutamine expansion diseases. Neurology 88:1114\u20131119","journal-title":"Neurology"},{"key":"2957_CR21","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","volume":"58","author":"L Dai","year":"2021","unstructured":"Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z (2021) Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Neurobiol 58:2183\u20132201","journal-title":"Mol Neurobiol"},{"key":"2957_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3233\/JHD-140111","volume":"3","author":"MY Davis","year":"2014","unstructured":"Davis MY, Keene CD, Jayadev S, Bird T (2014) The co-occurrence of Alzheimer\u2019s disease and Huntington\u2019s disease: a neuropathological study of 15 elderly Huntington\u2019s disease subjects. J Huntingtons Dis 3:209\u2013217","journal-title":"J Huntingtons Dis"},{"key":"2957_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JHD-210478","volume":"10","author":"M Davis","year":"2021","unstructured":"Davis M, Wheelock V, Talman L, Latimer C, Vicars B, Lin A, Jayadev S, Bird T (2021) Subdural hematoma as a serious complication of Huntington\u2019s disease: an observational study. J Huntingtons Dis 10:385\u2013390","journal-title":"J Huntingtons Dis"},{"key":"2957_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","volume":"115","author":"D del Toro","year":"2010","unstructured":"del Toro D, Xifr\u00f3 X, Pol A, Humbert S, Saudou F, Canals JM, Alberch J (2010) Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease. J Neurochem 115:153\u2013167","journal-title":"J Neurochem"},{"key":"2957_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagac\u00e9 M, Kuan WL, Saint-Pierre M, Dury RJ, Alata W, St-Amour I, Mason SL, Calon F, Lacroix S, Gowland PA, Francis ST, Barker RA, Cicchetti F (2015) Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol 78:160\u2013177","journal-title":"Ann Neurol"},{"key":"2957_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/mds.10341","volume":"18","author":"S Evers","year":"2003","unstructured":"Evers S, St\u00f6gbauer F (2003) Genetic association of Huntington\u2019s disease and restless legs syndrome? A family report. Mov Disord 18:225\u2013227","journal-title":"Mov Disord"},{"key":"2957_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","volume":"27","author":"LA Farrer","year":"1985","unstructured":"Farrer LA (1985) Diabetes mellitus in huntington disease. Clin Genet 27:62\u201367","journal-title":"Clin Genet"},{"key":"2957_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5334\/tohm.351","volume":"10","author":"E Feinstein","year":"2020","unstructured":"Feinstein E, Walker R (2020) Treatment of secondary chorea: a review of the current literature. Tremor Other Hyperkinet Mov (N Y) 10:22","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2957_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28855","volume":"37","author":"JJ Ferreira","year":"2022","unstructured":"Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C (2022) An MDS evidence-based review on treatments for Huntington\u2019s disease. Mov Disord 37:25\u201335","journal-title":"Mov Disord"},{"key":"2957_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00415-022-11418-y","volume":"270","author":"H Furby","year":"2023","unstructured":"Furby H, Moore S, Nordstroem AL, Houghton R, Lambrelli D, Graham S, Svenningsson P, Peters\u00e9n \u00c5 (2023) Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington\u2019s disease: a study of linked Swedish National registries (2002\u20132019). J Neurol 270:864\u2013876","journal-title":"J Neurol"},{"key":"2957_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/acs.biochem.5b00900","volume":"55","author":"X Gao","year":"2016","unstructured":"Gao X, Campbell WAt, Chaibva M, Jain P, Leslie AE, Frey SL, Legleiter J (2016) Cholesterol modifies Huntingtin binding to, disruption of, and aggregation on lipid membranes. Biochemistry 55:92\u2013102","journal-title":"Biochemistry"},{"key":"2957_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1134\/S1022795420030059","volume":"56","author":"DE Gomboeva","year":"2020","unstructured":"Gomboeva DE, Bragina EY, Nazarenko MS, Puzyrev VP (2020) Comorbidity between oncological diseases and Huntington\u2019s disease: review of epidemiological and biological evidence. Russ J Genet 56:269\u2013279 DOI 210.1134\/S1022795420030059","journal-title":"Russ J Genet"},{"key":"2957_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/mds.28089","volume":"35","author":"E Gonz\u00e1lez-Guevara","year":"2020","unstructured":"Gonz\u00e1lez-Guevara E, C\u00e1rdenas G, P\u00e9rez-Severiano F, Mart\u00ednez-Lazcano JC (2020) Dysregulated brain cholesterol metabolism is linked to neuroinflammation in Huntington\u2019s disease. Mov Disord 35:1113\u20131127","journal-title":"Mov Disord"},{"key":"2957_CR34","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00415-012-6484-8","volume":"259","author":"A Haghikia","year":"2012","unstructured":"Haghikia A, D\u00e9card BF, Hellwig K, Kraus P, Gold R (2012) Wheels within wheels: multifocal autoimmune myelitis in a woman with Huntington\u2019s disease. J Neurol 259:1973\u20131975","journal-title":"J Neurol"},{"key":"2957_CR35","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1210\/jc.2012-1190","volume":"97","author":"K Hashimoto","year":"2012","unstructured":"Hashimoto K, Ito Y, Tanahashi H, Hayashi M, Yamakita N, Yasuda K (2012) Hyperglycemic chorea-ballism or acute exacerbation of Huntington\u2019s chorea? Huntington\u2019s disease unmasked by diabetic ketoacidosis in type 1 diabetes mellitus. J Clin Endocrinol Metab 97:3016\u20133020","journal-title":"J Clin Endocrinol Metab"},{"key":"2957_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3233\/JHD-230586","volume":"12","author":"LF Hasholt","year":"2023","unstructured":"Hasholt LF (2023) Upregulated chaperone-mediated autophagy May perform a key role in reduced cancer incidence in Huntington\u2019s disease. J Huntingtons Dis 12:371\u2013376","journal-title":"J Huntingtons Dis"},{"key":"2957_CR37","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1089\/ars.2024.0674","volume":"41","author":"K He","year":"2024","unstructured":"He K, Zhao Z, Zhang J, Li D, Wang S, Liu Q (2024) Cholesterol metabolism in neurodegenerative diseases. Antioxid Redox Signal 41:1051\u20131072","journal-title":"Antioxid Redox Signal"},{"key":"2957_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3233\/JAD-131847","volume":"40","author":"Y Hu","year":"2014","unstructured":"Hu Y, Liang J, Yu S (2014) High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington\u2019s disease. J Alzheimers Dis 40:863\u2013868","journal-title":"J Alzheimers Dis"},{"key":"2957_CR39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s007020050095","volume":"105","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA (1998) Alzheimer-type lesions in Huntington\u2019s disease. J Neural Transm (Vienna) 105:787\u2013799","journal-title":"J Neural Transm (Vienna)"},{"key":"2957_CR40","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00702-024-02750-w","volume":"131","author":"KA Jellinger","year":"2024","unstructured":"Jellinger KA (2024a) The pathobiology of depression in Huntington\u2019s disease: an unresolved puzzle. J Neural Transm (Vienna) 131:1511\u20131522","journal-title":"J Neural Transm (Vienna)"},{"key":"2957_CR41","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00702-024-02794-y","volume":"131","author":"KA Jellinger","year":"2024","unstructured":"Jellinger KA (2024b) Pathomechanisms of behavioral abnormalities in huntington disease: an update. J Neural Transm (Vienna) 131:999\u20131012","journal-title":"J Neural Transm (Vienna)"},{"key":"2957_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00702-024-02792-0","volume":"131","author":"KA Jellinger","year":"2024","unstructured":"Jellinger KA (2024c) Depression and anxiety in multiple sclerosis. Review of a fatal combination. J Neural Transm (Vienna) 131:847\u2013869","journal-title":"J Neural Transm (Vienna)"},{"key":"2957_CR43","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S1470-2045(12)70132-8","volume":"13","author":"J Ji","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J (2012) Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. Lancet Oncol 13:642\u2013648","journal-title":"Lancet Oncol"},{"key":"2957_CR44","doi-asserted-by":"crossref","unstructured":"Jiang LL, Zhang XL, Hu HY (2024) Co-aggregation of TDP-43 with other pathogenic proteins and their co-pathologies in neurodegenerative diseases. Int J Mol Sci 25:12380","DOI":"10.3390\/ijms252212380"},{"key":"2957_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/psyg.12040","volume":"14","author":"I Kawakami","year":"2014","unstructured":"Kawakami I, Katsuse O, Aoki N, Togo T, Suzuki K, Isojima D, Kondo D, Iseki E, Kosaka K, Akiyama H, Hirayasu Y (2014) Autopsy case of concurrent Huntington\u2019s disease and neurofibromatosis type 1. Psychogeriatrics 14:81\u201386","journal-title":"Psychogeriatrics"},{"key":"2957_CR46","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1113\/jphysiol.2012.238113","volume":"590","author":"H Kiriazis","year":"2012","unstructured":"Kiriazis H, Jennings NL, Davern P, Lambert G, Su Y, Pang T, Du X, La Greca L, Head GA, Hannan AJ, Du XJ (2012) Neurocardiac dysregulation and neurogenic arrhythmias in a Transgenic mouse model of Huntington\u2019s disease. J Physiol 590:5845\u20135860","journal-title":"J Physiol"},{"key":"2957_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jns.2016.10.033","volume":"372","author":"J Kobal","year":"2017","unstructured":"Kobal J, Cankar K, Pretnar J, Zaletel M, Kobal L, Teran N, Melik Z (2017) Functional impairment of precerebral arteries in huntington disease. J Neurol Sci 372:363\u2013368","journal-title":"J Neurol Sci"},{"key":"2957_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3233\/JHD-150170","volume":"4","author":"F Kreilaus","year":"2015","unstructured":"Kreilaus F, Spiro AS, Hannan AJ, Garner B, Jenner AM (2015) Brain cholesterol synthesis and metabolism is progressively disturbed in the R6\/1 mouse model of Huntington\u2019s disease: a targeted GC-MS\/MS sterol analysis. J Huntingtons Dis 4:305\u2013318","journal-title":"J Huntingtons Dis"},{"key":"2957_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/nan.12286","volume":"42","author":"F Kreilaus","year":"2016","unstructured":"Kreilaus F, Spiro AS, McLean CA, Garner B, Jenner AM (2016) Evidence for altered cholesterol metabolism in Huntington\u2019s disease post mortem brain tissue. Neuropathol Appl Neurobiol 42:535\u2013546","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2957_CR50","doi-asserted-by":"publisher","first-page":"829076","DOI":"10.3389\/fneur.2022.829076","volume":"13","author":"K Kyle","year":"2022","unstructured":"Kyle K, Bordelon Y, Venna N, Linnoila J (2022) Autoimmune and paraneoplastic chorea: a review of the literature. Front Neurol 13:829076","journal-title":"Front Neurol"},{"key":"2957_CR51","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archneur.65.4.476","volume":"65","author":"NM Lalic","year":"2008","unstructured":"Lalic NM, Maric J, Svetel M, Jotic A, Stefanova E, Lalic K, Dragasevic N, Milicic T, Lukic L, Kostic VS (2008) Glucose homeostasis in huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol 65:476\u2013480","journal-title":"Arch Neurol"},{"key":"2957_CR52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbrc.2014.01.188","volume":"446","author":"V Leoni","year":"2014","unstructured":"Leoni V, Caccia C (2014) Study of cholesterol metabolism in Huntington\u2019s disease. Biochem Biophys Res Commun 446:697\u2013701","journal-title":"Biochem Biophys Res Commun"},{"key":"2957_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.clineuro.2015.05.006","volume":"136","author":"HW Maloni","year":"2015","unstructured":"Maloni HW, Wallin MT (2015) Presentation of multiple sclerosis with comorbid Huntington\u2019s disease. Clin Neurol Neurosurg 136:86\u201388","journal-title":"Clin Neurol Neurosurg"},{"key":"2957_CR54","first-page":"34","volume":"4","author":"S Marini","year":"2021","unstructured":"Marini S, Kaku M, Bissonnette SL, Dubaz O (2021) Comorbid multiple sclerosis and Huntington\u2019s disease. Acta Scient Neurol 4:34\u201336. https:\/\/actascientific.com\/ASNE\/ASNE-04-0419.php","journal-title":"Acta Scient Neurol"},{"key":"2957_CR55","doi-asserted-by":"crossref","unstructured":"Mart\u00ed-Mart\u00ednez S, Valor LM (2022) A glimpse of molecular biomarkers in Huntington\u2019s disease. Int J Mol Sci 23:5411","DOI":"10.3390\/ijms23105411"},{"key":"2957_CR56","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2337\/db08-0799","volume":"58","author":"B Martin","year":"2009","unstructured":"Martin B, Golden E, Carlson OD, Pistell P, Zhou J, Kim W, Frank BP, Thomas S, Chadwick WA, Greig NH, Bates GP, Sathasivam K, Bernier M, Maudsley S, Mattson MP, Egan JM (2009) Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease. Diabetes 58:318\u2013328","journal-title":"Diabetes"},{"key":"2957_CR57","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/acn3.52031","volume":"11","author":"S Martinez-Horta","year":"2024","unstructured":"Martinez-Horta S, Perez-Perez J, Perez-Gonzalez R, Sampedro F, Horta-Barba A, Campolongo A, Rivas-Asensio E, Puig-Davi A, Pagonabarraga J, Kulisevsky J (2024) Cognitive phenotype and neurodegeneration associated with Tau in Huntington\u2019s disease. Ann Clin Transl Neurol 11:1160\u20131171","journal-title":"Ann Clin Transl Neurol"},{"key":"2957_CR58","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ana.410030616","volume":"3","author":"GC McIntosh","year":"1978","unstructured":"McIntosh GC, Jameson HD, Markesbery WR (1978) Huntington disease associated with Alzheimer disease. Ann Neurol 3:545\u2013548","journal-title":"Ann Neurol"},{"key":"2957_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3233\/JHD-170263","volume":"7","author":"P McNulty","year":"2018","unstructured":"McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L (2018) Reduced cancer incidence in Huntington\u2019s disease: analysis in the registry study. J Huntingtons Dis 7:209\u2013222","journal-title":"J Huntingtons Dis"},{"key":"2957_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-230569","volume":"12","author":"I Mees","year":"2023","unstructured":"Mees I, Nisbet RM, Hannan AJ, Renoir T (2023) Implications of Tau dysregulation in Huntington\u2019s disease and potential for new therapeutics. J Huntingtons Dis 12:1\u201313","journal-title":"J Huntingtons Dis"},{"key":"2957_CR61","first-page":"325","volume":"2","author":"GC Melkani","year":"2016","unstructured":"Melkani GC (2016) Huntington\u2019s disease-induced cardiac disorders affect multiple cellular pathways. React Oxyg Species (Apex) 2:325\u2013338","journal-title":"React Oxyg Species (Apex)"},{"key":"2957_CR62","unstructured":"Mills J, Long J, Vaidya J, Sampaio C, Sathe S (2022) Comorbidities in Huntington\u2019s disease: an Enroll-HD analysis [abstract]. Mov Disord 37 (suppl 2):647. https:\/\/www.mdsabstracts.org\/abstract\/comorbidities-in-huntingtons-disease-an-enroll-hd-analysis"},{"key":"2957_CR63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/JHD-170253","volume":"6","author":"MT Montojo","year":"2017","unstructured":"Montojo MT, Aganzo M, Gonz\u00e1lez N (2017) Huntington\u2019s disease and diabetes: chronological sequence of its association. J Huntingtons Dis 6:179\u2013188","journal-title":"J Huntingtons Dis"},{"key":"2957_CR64","doi-asserted-by":"crossref","unstructured":"Morena E, Romano C, Marconi M, Diamant S, Buscarinu MC, Bellucci G, Romano S, Scarabino D, Salvetti M, Ristori G (2023) Peripheral biomarkers in manifest and premanifest Huntington\u2019s disease. Int J Mol Sci 24:6051","DOI":"10.3390\/ijms24076051"},{"key":"2957_CR65","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1532-5415.1988.tb01807.x","volume":"36","author":"RJ Moss","year":"1988","unstructured":"Moss RJ, Mastri AR, Schut LJ (1988) The coexistence and differentiation of late onset Huntington\u2019s disease and Alzheimer\u2019s disease. A case report and review of the literature. J Am Geriatr Soc 36:237\u2013241","journal-title":"J Am Geriatr Soc"},{"key":"2957_CR66","doi-asserted-by":"crossref","unstructured":"Nguyen TB, Miramontes R, Chillon-Marinas C, Maimon R, Vazquez-Sanchez S, Lau AL, McClure NR, England WE, Singha M, Stocksdale JT, Jang KH, Jung S, McKnight JI, Ho LN, Faull RLM, Steffan JS, Reidling JC, Jang C, Lee G, Cleveland DW, Lagier-Tourenne C, Spitale RC, Thompson LM (2023) Aberrant splicing in Huntington\u2019s disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification [PREPRINT]. bioRxiv:10.31.565004. doi: 565010.561101\/562023.565010.565031.565004","DOI":"10.1101\/2023.10.31.565004"},{"key":"2957_CR69","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1212\/WNL.0b013e3182886991","volume":"80","author":"O O\u2019Toole","year":"2013","unstructured":"O\u2019Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A (2013) Autoimmune chorea in adults. Neurology 80:1133\u20131144","journal-title":"Neurology"},{"key":"2957_CR67","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/mds.28460","volume":"36","author":"AC Ogilvie","year":"2021","unstructured":"Ogilvie AC, Gonzalez-Alegre P, Schultz JL (2021) Diabetes mellitus is associated with an earlier age of onset of Huntington\u2019s disease. Mov Disord 36:1033\u20131034","journal-title":"Mov Disord"},{"key":"2957_CR68","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3109\/21678421.2014.952238","volume":"16","author":"B Oskarsson","year":"2015","unstructured":"Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW (2015) A case of Familial ALS due to multi-system proteinopathy 1 and huntington disease. Amyotroph Lateral Scler Frontotemporal Degener 16:124\u2013126","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2957_CR70","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/NRL.0b013e3182173567","volume":"17","author":"M Panas","year":"2011","unstructured":"Panas M, Karadima G, Kalfakis N, Vassilopoulos D (2011) Co-segregation of huntington disease and hereditary spastic paraplegia in 4 generations. Neurologist 17:211\u2013212","journal-title":"Neurologist"},{"key":"2957_CR71","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jocn.2021.09.012","volume":"93","author":"PK Panegyres","year":"2021","unstructured":"Panegyres PK, Chen HY (2021) Alzheimer\u2019s disease, Huntington\u2019s disease and cancer. J Clin Neurosci 93:103\u2013105","journal-title":"J Clin Neurosci"},{"key":"2957_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/02688690601000956","volume":"20","author":"I Pechlivanis","year":"2006","unstructured":"Pechlivanis I, Andrich J, Scholz M, Harders A, Saft C, Schmieder K (2006) Chronic subdural haematoma in patients with Huntington\u2019s disease. Br J Neurosurg 20:327\u2013329","journal-title":"Br J Neurosurg"},{"key":"2957_CR73","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JHD-180321","volume":"8","author":"AC Pfalzer","year":"2019","unstructured":"Pfalzer AC, Wages PA, Porter NA, Bowman AB (2019) Striatal cholesterol precursors are altered with age in female Huntington\u2019s disease model mice. J Huntingtons Dis 8:161\u2013169","journal-title":"J Huntingtons Dis"},{"key":"2957_CR74","doi-asserted-by":"publisher","first-page":"20314","DOI":"10.1038\/s41598-020-76973-8","volume":"10","author":"GR Phillips","year":"2020","unstructured":"Phillips GR, Hancock SE, Brown SHJ, Jenner AM, Kreilaus F, Newell KA, Mitchell TW (2020) Cholesteryl ester levels are elevated in the caudate and putamen of Huntington\u2019s disease patients. Sci Rep 10:20314","journal-title":"Sci Rep"},{"key":"2957_CR75","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3389\/fphar.2020.00779","volume":"11","author":"S Rea","year":"2020","unstructured":"Rea S, Della-Morte D, Pacifici F, Capuani B, Pastore D, Coppola A, Arriga R, Andreadi A, Donadel G, Di Daniele N, Bellia A, Lauro D (2020) Insulin and exendin-4 reduced mutated Huntingtin accumulation in neuronal cells. Front Pharmacol 11:779","journal-title":"Front Pharmacol"},{"key":"2957_CR76","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.35.2.273","volume":"35","author":"MG Reyes","year":"1985","unstructured":"Reyes MG, Gibbons S (1985) Dementia of the Alzheimer\u2019s type and Huntington\u2019s disease. Neurology 35:273\u2013277","journal-title":"Neurology"},{"key":"2957_CR77","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1038\/s41380-020-0787-4","volume":"26","author":"M Rieux","year":"2021","unstructured":"Rieux M, Alpaugh M, Sciacca G, Saint-Pierre M, Masnata M, Denis HL, L\u00e9vesque SA, Herrmann F, Bazenet C, Garneau AP, Isenring P, Truant R, Oueslati A, Gould PV, Ast A, Wanker EE, Lacroix S, Cicchetti F (2021) Shedding a new light on Huntington\u2019s disease: how blood can both propagate and ameliorate disease pathology. Mol Psychiatry 26:5441\u20135463","journal-title":"Mol Psychiatry"},{"key":"2957_CR78","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/hmg\/ddae137","volume":"33","author":"AK Roos","year":"2024","unstructured":"Roos AK, Stenvall E, Kockum ES, Gr\u00f6nlund K\u00c5, Alstermark H, Wuolikainen A, Andersen PM, Nordin A, Forsberg KME (2024) Small striatal Huntingtin inclusions in patients with motor neuron disease with reduced penetrance and intermediate HTT gene expansions. Hum Mol Genet 33:1966\u20131974","journal-title":"Hum Mol Genet"},{"key":"2957_CR79","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s004010050539","volume":"92","author":"A Rubio","year":"1996","unstructured":"Rubio A, Steinberg K, Figlewicz DA, MacDonald ME, Greenamyre T, Hamill R, Shoulson I, Powers JM (1996) Coexistence of Huntington\u2019s disease and Familial amyotrophic lateral sclerosis: case presentation. Acta Neuropathol 92:421\u2013427","journal-title":"Acta Neuropathol"},{"key":"2957_CR80","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JHD-130078","volume":"2","author":"CV Russo","year":"2013","unstructured":"Russo CV, Salvatore E, Sacc\u00e0 F, Tucci T, Rinaldi C, Sorrentino P, Massarelli M, Rossi F, Savastano S, Di Maio L, Filla A, Colao A, De Michele G (2013) Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington\u2019s disease patients. J Huntingtons Dis 2:501\u2013507","journal-title":"J Huntingtons Dis"},{"key":"2957_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JHD-220557","volume":"12","author":"S Salem","year":"2023","unstructured":"Salem S, Cicchetti F (2023) Untangling the role of Tau in Huntington\u2019s disease pathology. J Huntingtons Dis 12:15\u201329","journal-title":"J Huntingtons Dis"},{"key":"2957_CR82","doi-asserted-by":"publisher","first-page":"106542","DOI":"10.1016\/j.nbd.2024.106542","volume":"198","author":"S Salem","year":"2024","unstructured":"Salem S, Kilgore MD, Anwer M, Maxan A, Child D, Bird TD, Keene CD, Cicchetti F, Latimer C (2024) Evidence of mutant Huntingtin and tau-related pathology within neuronal grafts in Huntington\u2019s disease cases. Neurobiol Dis 198:106542","journal-title":"Neurobiol Dis"},{"key":"2957_CR83","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00062-022-01150-5","volume":"32","author":"F Sampedro","year":"2022","unstructured":"Sampedro F, Mart\u00ednez-Horta S, P\u00e9rez-P\u00e9rez J, P\u00e9rez-Gonz\u00e1lez R, Horta-Barba A, Campolongo A, Izquierdo C, Aracil-Bola\u00f1os I, Rivas E, Puig-Davi A, Pagonabarraga J, G\u00f3mez-Ans\u00f3n B, Kulisevsky J (2022) Plasma TDP-43 reflects cortical neurodegeneration and correlates with neuropsychiatric symptoms in Huntington\u2019s disease. Clin Neuroradiol 32:1077\u20131085","journal-title":"Clin Neuroradiol"},{"key":"2957_CR84","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1038\/s41598-022-08924-4","volume":"12","author":"RPM Santos","year":"2022","unstructured":"Santos RPM, Ribeiro R, Ferreira-Vieira TH, Aires RD, de Souza JM, Oliveira BS, Lima ALD, de Oliveira ACP, Reis HJ, de Miranda AS, Vieira EML, Ribeiro FM, Vieira LB (2022) Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington\u2019s disease. Sci Rep 12:5621","journal-title":"Sci Rep"},{"key":"2957_CR85","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1600-0404.2008.01091.x","volume":"119","author":"E Savva","year":"2009","unstructured":"Savva E, Schnorf H, Burkhard PR (2009) Restless legs syndrome: an early manifestation of Huntington\u2019s disease? Acta Neurol Scand 119:274\u2013276","journal-title":"Acta Neurol Scand"},{"key":"2957_CR86","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.3233\/JAD-190851","volume":"72","author":"N Sawant","year":"2019","unstructured":"Sawant N, Reddy PH (2019) Role of phosphorylated Tau and glucose synthase kinase 3 beta in Huntington\u2019s disease progression. J Alzheimers Dis 72:S177\u2013S191","journal-title":"J Alzheimers Dis"},{"key":"2957_CR87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JHD-120044","volume":"2","author":"SJ Sch\u00f6nberger","year":"2013","unstructured":"Sch\u00f6nberger SJ, Jezdic D, Faull RL, Cooper GJ (2013) Proteomic analysis of the human brain in Huntington\u2019s disease indicates pathogenesis by molecular processes linked to other neurodegenerative diseases and to type-2 diabetes. J Huntingtons Dis 2:89\u201399","journal-title":"J Huntingtons Dis"},{"key":"2957_CR88","doi-asserted-by":"publisher","first-page":"e0147269","DOI":"10.1371\/journal.pone.0147269","volume":"11","author":"AM Schroeder","year":"2016","unstructured":"Schroeder AM, Wang HB, Park S, Jordan MC, Gao F, Coppola G, Fishbein MC, Roos KP, Ghiani CA, Colwell CS (2016) Cardiac dysfunction in the BACHD mouse model of Huntington\u2019s disease. PLoS ONE 11:e0147269","journal-title":"PLoS ONE"},{"key":"2957_CR89","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3233\/JHD-180287","volume":"7","author":"JL Schultz","year":"2018","unstructured":"Schultz JL, Nopoulos PC, Gonzalez-Alegre P (2018) Human immunodeficiency virus infection in Huntington\u2019s disease is associated with an earlier age of symptom onset. J Huntingtons Dis 7:163\u2013166","journal-title":"J Huntingtons Dis"},{"key":"2957_CR90","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/mds.27591","volume":"34","author":"JL Schultz","year":"2019","unstructured":"Schultz JL, Nopoulos PC, Killoran A, Kamholz JA (2019) Statin use and delayed onset of Huntington\u2019s disease. Mov Disord 34:281\u2013285","journal-title":"Mov Disord"},{"key":"2957_CR91","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/mds.28062","volume":"35","author":"JL Schultz","year":"2020","unstructured":"Schultz JL, Harshman LA, Langbehn DR, Nopoulos PC (2020) Hypertension is associated with an earlier age of onset of Huntington\u2019s disease. Mov Disord 35:1558\u20131564","journal-title":"Mov Disord"},{"key":"2957_CR92","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaneurol.2024.4108","volume":"82","author":"JL Schultz","year":"2025","unstructured":"Schultz JL, Ogilvie AC, Harshman LA, Nopoulos PC (2025) Beta-blocker use and delayed onset and progression of huntington disease. JAMA Neurol 82:85\u201392","journal-title":"JAMA Neurol"},{"key":"2957_CR93","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and Huntingtin in inclusions of huntington disease. J Neuropathol Exp Neurol 67:1159\u20131165","journal-title":"J Neuropathol Exp Neurol"},{"key":"2957_CR94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/ane.12512","volume":"134","author":"JO Sipil\u00e4","year":"2016","unstructured":"Sipil\u00e4 JO, Majamaa K (2016) Epidemiology of stroke in Finnish patients with Huntington\u2019s disease. Acta Neurol Scand 134:61\u201366","journal-title":"Acta Neurol Scand"},{"key":"2957_CR95","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00701-016-2845-x","volume":"158","author":"JO Sipil\u00e4","year":"2016","unstructured":"Sipil\u00e4 JO, Posti JP, Majamaa K (2016) Chronic subdural hematomas in Finnish patients with Huntington\u2019s disease. Acta Neurochir (Wien) 158:1487\u20131490","journal-title":"Acta Neurochir (Wien)"},{"key":"2957_CR96","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.1074\/jbc.M110338200","volume":"277","author":"C Song","year":"2002","unstructured":"Song C, Perides G, Liu YF (2002) Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells. J Biol Chem 277:6703\u20136707","journal-title":"J Biol Chem"},{"key":"2957_CR97","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.0.CO;2-3","volume":"86","author":"SA S\u00f8rensen","year":"1999","unstructured":"S\u00f8rensen SA, Fenger K, Olsen JH (1999) Significantly lower incidence of cancer among patients with huntington disease: an apoptotic effect of an expanded polyglutamine tract? Cancer 86:1342\u20131346","journal-title":"Cancer"},{"key":"2957_CR98","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","volume":"135","author":"I St-Amour","year":"2018","unstructured":"St-Amour I, Turgeon A, Goupil C, Planel E, H\u00e9bert SS (2018) Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease. Acta Neuropathol 135:249\u2013265","journal-title":"Acta Neuropathol"},{"key":"2957_CR99","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2957_CR100","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/mdc3.12596","volume":"5","author":"CD Stephen","year":"2018","unstructured":"Stephen CD, Hung J, Schifitto G, Hersch SM, Rosas HD (2018) Electrocardiogram abnormalities suggest aberrant cardiac conduction in Huntington\u2019s disease. Mov Disord Clin Pract 5:306\u2013311","journal-title":"Mov Disord Clin Pract"},{"key":"2957_CR101","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/mds.27976","volume":"35","author":"JJ Steventon","year":"2020","unstructured":"Steventon JJ, Rosser AE, Hart E, Murphy K (2020) Hypertension, antihypertensive use and the delayed-onset of Huntington\u2019s disease. Mov Disord 35:937\u2013946","journal-title":"Mov Disord"},{"key":"2957_CR102","doi-asserted-by":"publisher","first-page":"e4642","DOI":"10.1002\/pro.4642","volume":"32","author":"AR Stonebraker","year":"2023","unstructured":"Stonebraker AR, Beasley M, Massinople S, Wunder M, Li P, Valentine SJ, Legleiter J (2023) Cholesterol impacts the formation of huntingtin\/lipid complexes and subsequent aggregation. Protein Sci 32:e4642","journal-title":"Protein Sci"},{"key":"2957_CR103","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","volume":"124","author":"M Tada","year":"2012","unstructured":"Tada M, Coon EA, Osmand AP, Kirby PA, Martin W, Wieler M, Shiga A, Shirasaki H, Makifuchi T, Yamada M, Kakita A, Nishizawa M, Takahashi H, Paulson HL (2012) Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol 124:749\u2013760","journal-title":"Acta Neuropathol"},{"key":"2957_CR104","doi-asserted-by":"publisher","first-page":"106829","DOI":"10.1016\/j.nbd.2025.106829","volume":"206","author":"AYS Tan","year":"2025","unstructured":"Tan AYS, Martinez L, Murray HC, Mehrabi NF, Tippett LJ, Turner CP, Curtis MA, Faull RLM, Dragunow M, Singh-Bains MK (2025) Elucidating cortical neurovascular involvement in Huntington\u2019s disease using human brain tissue microarrays. Neurobiol Dis 206:106829","journal-title":"Neurobiol Dis"},{"key":"2957_CR106","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JHD-180290","volume":"7","author":"MS Thion","year":"2018","unstructured":"Thion MS, Humbert S (2018) Cancer: from wild-type to mutant Huntingtin. J Huntingtons Dis 7:201\u2013208","journal-title":"J Huntingtons Dis"},{"key":"2957_CR105","doi-asserted-by":"crossref","unstructured":"Thion MS, McGuire JR, Sousa CM, Fuhrmann L, Fitamant J, Leboucher S, Vacher S, du Montcel ST, Bi\u00e8che I, Bernet A, Mehlen P, Vincent-Salomon A, Humbert S (2015) Unraveling the role of Huntingtin in breast cancer metastasis. J Natl Cancer Inst 107: djv208","DOI":"10.1093\/jnci\/djv208"},{"key":"2957_CR107","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/cge.12010","volume":"83","author":"MR Turner","year":"2013","unstructured":"Turner MR, Goldacre R, Goldacre MJ (2013) Reduced cancer incidence in Huntington\u2019s disease: record linkage study clue to an evolutionary trade-off? Clin Genet 83:588\u2013590","journal-title":"Clin Genet"},{"key":"2957_CR108","doi-asserted-by":"publisher","first-page":"e0197975","DOI":"10.1371\/journal.pone.0197975","volume":"13","author":"L Valc\u00e1rcel-Ocete","year":"2018","unstructured":"Valc\u00e1rcel-Ocete L, Fullaondo A, Alkorta-Aranburu G, Garc\u00eda-Barcina M, Roos RAC, Hjermind LE, Saft C, Frontali M, Reilmann R, Rickards H, Zubiaga AM, Aguirre A (2018) Does arterial hypertension influence the onset of Huntington\u2019s disease? PLoS ONE 13:e0197975","journal-title":"PLoS ONE"},{"key":"2957_CR109","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi M, Mariotti C, Di Donato S, Corsini A, Bates G, Pruss R, Olson JM, Sipione S, Tartari M, Cattaneo E (2005) Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci 25:9932\u20139939","journal-title":"J Neurosci"},{"key":"2957_CR110","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O, MacDonald M, Wellington C, DiDonato S, Hayden M, Cattaneo E (2010) Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci 30:10844\u201310850","journal-title":"J Neurosci"},{"key":"2957_CR111","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"2957_CR112","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/brain\/awv107","volume":"138","author":"R Vuono","year":"2015","unstructured":"Vuono R, Winder-Rhodes S, de Silva R, Cisbani G, Drouin-Ouellet J, Spillantini MG, Cicchetti F, Barker RA (2015) The role of Tau in the pathological process and clinical expression of Huntington\u2019s disease. Brain 138:1907\u20131918","journal-title":"Brain"},{"key":"2957_CR113","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphys.2014.00231","volume":"5","author":"R Wang","year":"2014","unstructured":"Wang R, Ross CA, Cai H, Cong WN, Daimon CM, Carlson OD, Egan JM, Siddiqui S, Maudsley S, Martin B (2014) Metabolic and hormonal signatures in pre-manifest and manifest Huntington\u2019s disease patients. Front Physiol 5:231","journal-title":"Front Physiol"},{"key":"2957_CR114","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JHD-2012-120004","volume":"1","author":"NI Wood","year":"2012","unstructured":"Wood NI, Sawiak SJ, Buonincontri G, Niu Y, Kane AD, Carpenter TA, Giussani DA, Morton AJ (2012) Direct evidence of progressive cardiac dysfunction in a Transgenic mouse model of Huntington\u2019s disease. J Huntingtons Dis 1:57\u201364","journal-title":"J Huntingtons Dis"},{"key":"2957_CR115","doi-asserted-by":"publisher","first-page":"1402996","DOI":"10.3389\/fnins.2024.1402996","volume":"18","author":"Y Wu","year":"2024","unstructured":"Wu Y, Wang Y, Lu Y, Yan J, Zhao H, Yang R, Pan J (2024) Research advances in huntingtin-associated protein 1 and its application prospects in diseases. Front Neurosci 18:1402996","journal-title":"Front Neurosci"},{"key":"2957_CR116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-022-01379-8","volume":"10","author":"D Yu","year":"2022","unstructured":"Yu D, Zarate N, White A, Coates D, Tsai W, Nanclares C, Cuccu F, Yue JS, Brown TG, Mansky RH, Jiang K, Kim H, Nichols-Meade T, Larson SN, Gundry K, Zhang Y, Tomas-Zapico C, Lucas JJ, Benneyworth M, \u00d6z G, Cvetanovic M, Araque A, Gomez-Pastor R (2022) CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington\u2019s disease. Acta Neuropathol Commun 10:83","journal-title":"Acta Neuropathol Commun"},{"key":"2957_CR117","doi-asserted-by":"publisher","first-page":"1155638","DOI":"10.3389\/fendo.2023.1155638","volume":"14","author":"J Zheng","year":"2023","unstructured":"Zheng J, Wu X (2023) Chorea: an unusual manifestation of endocrine diseases. Front Endocrinol (Lausanne) 14:1155638","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2957_CR118","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3892\/or.2013.2303","volume":"29","author":"L Zhu","year":"2013","unstructured":"Zhu L, Song X, Tang J, Wu J, Ma R, Cao H, Ji M, Jing C, Wang Z (2013) Huntingtin-associated protein 1: a potential biomarker of breast cancer. Oncol Rep 29:1881\u20131887","journal-title":"Oncol Rep"},{"key":"2957_CR119","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/hmg\/ddz295","volume":"29","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Shamblin I, Rodriguez E, Salzer GE, Araysi L, Margolies KA, Halade GV, Litovsky SH, Pogwizd S, Gray M, Huke S (2020) Progressive cardiac arrhythmias and ECG abnormalities in the Huntington\u2019s disease BACHD mouse model. Hum Mol Genet 29:369\u2013381","journal-title":"Hum Mol Genet"},{"key":"2957_CR120","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13023-023-02734-1","volume":"18","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Li M, Bai J, Wang H, Huang X (2023) Hypertension, antihypertensive drugs, and age at onset of Huntington\u2019s disease. Orphanet J Rare Dis 18:125","journal-title":"Orphanet J Rare Dis"},{"key":"2957_CR121","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fmed.2020.00079","volume":"7","author":"D Zielonka","year":"2020","unstructured":"Zielonka D, Witkowski G, Puch EA, Lesniczak M, Mazur-Michalek I, Isalan M, Mielcarek M (2020) Prevalence of non-psychiatric comorbidities in pre-symptomatic and symptomatic Huntington\u2019s disease gene carriers in Poland. Front Med (Lausanne) 7:79","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02957-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:09:42Z","timestamp":1759169382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":121,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2957"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02957-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}